Our faculty author, co-author and contribute to more than 1500 peer-reviewed scientific publications each year. Find their recent publications below, and filter by division.
Search the faculty directory to find an individual's list of publications.
Publications
Noyd, David H., Nigel B. Neely, Kristin M. Schroeder, Paul M. Lantos, Steve Power, Susan G. Kreissman, and Kevin C. Oeffinger. “Integration of cancer registry and electronic health record data to construct a childhood cancer survivorship cohort, facilitate risk stratification for late effects, and assess appropriate follow-up care.” Pediatr Blood Cancer 68, no. 6 (June 2021): e29014. https://doi.org/10.1002/pbc.29014.
PMID
33742534
Kenney, Cara, Tricia Kunst, Santhana Webb, Devisser Christina, Christy Arrowood, Seth M. Steinberg, Niharika B. Mettu, Edward J. Kim, and Udo Rudloff. “Phase II study of selumetinib, an orally active inhibitor of MEK1 and MEK2 kinases, in KRASG12R-mutant pancreatic ductal adenocarcinoma.” Invest New Drugs 39, no. 3 (June 2021): 821–28. https://doi.org/10.1007/s10637-020-01044-8.
PMID
33405090
Tao, Jun, Aminah Jatoi, Jeffrey Crawford, Wendy W. T. Lam, James C. Ho, Xiaofei Wang, and Herbert Pang. “Role of dietary carbohydrates on risk of lung cancer.” Lung Cancer 155 (May 2021): 87–93. https://doi.org/10.1016/j.lungcan.2021.03.009.
PMID
33756357
Buechel, Megan E., Danielle Enserro, Robert A. Burger, Mark F. Brady, Katrina Wade, Angeles Alvarez Secord, Andrew B. Nixon, et al. “Correlation of imaging and plasma based biomarkers to predict response to bevacizumab in epithelial ovarian cancer (EOC).” Gynecol Oncol 161, no. 2 (May 2021): 382–88. https://doi.org/10.1016/j.ygyno.2021.02.032.
PMID
33712274
Halabi, Susan, and Andrew J. Armstrong. “Sarcomatoid Renal Cell Carcinoma: An Immune Checkpoint-responsive Subset?” Eur Urol 79, no. 5 (May 2021): 663–64. https://doi.org/10.1016/j.eururo.2021.01.042.
PMID
33593655
Armstrong, Andrew J., Neal D. Shore, Russell Z. Szmulewitz, Daniel P. Petrylak, Jeffrey Holzbeierlein, Arnauld Villers, Arun Azad, et al. “Reply by Authors.” J Urol 205, no. 5 (May 2021): 1371. https://doi.org/10.1097/JU.0000000000001568.02.
PMID
33705222
Armstrong, Andrew J., Neal D. Shore, Russell Z. Szmulewitz, Daniel P. Petrylak, Jeffrey Holzbeierlein, Arnauld Villers, Arun Azad, et al. “Efficacy of Enzalutamide plus Androgen Deprivation Therapy in Metastatic Hormone-Sensitive Prostate Cancer by Pattern of Metastatic Spread: ARCHES Post Hoc Analyses.” In J Urol, 205:1361–71, 2021. https://doi.org/10.1097/JU.0000000000001568.
PMID
33356529
Venugopal, Abhirami, Jessie Gillick-Walker, Agnes Michalczyk, Mustafa Khasraw, and M Leigh Ackland. “mRNA profiling of a well-differentiated G1 pancreatic NET correlates with immunohistochemistry profile: a case report.” Bmc Gastroenterol 21, no. 1 (April 27, 2021): 194. https://doi.org/10.1186/s12876-021-01705-9.
PMID
33906633
Taylor, Amelia M., David Lok Hang Chan, Martin Tio, Sujata M. Patil, Tiffany A. Traina, Mark E. Robson, and Mustafa Khasraw. “PARP (Poly ADP-Ribose Polymerase) inhibitors for locally advanced or metastatic breast cancer.” Cochrane Database Syst Rev 4 (April 22, 2021): CD011395. https://doi.org/10.1002/14651858.CD011395.pub2.
PMID
33886122
Scher, H. I., A. J. Armstrong, J. D. Schonhoft, A. Gill, J. L. Zhao, E. Barnett, E. Carbone, et al. “Development and validation of circulating tumour cell enumeration (Epic Sciences) as a prognostic biomarker in men with metastatic castration-resistant prostate cancer.” Eur J Cancer 150 (April 21, 2021): 83–94. https://doi.org/10.1016/j.ejca.2021.02.042.
PMID
33894633